Lv2
156 积分 2025-06-17 加入
Opportunities and challenges of targeting cGAS–STING in cancer
25天前
已完结
Opportunities and challenges of targeting cGAS–STING in cancer
28天前
已完结
Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial
1个月前
已完结
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
1个月前
已完结
Lessons from incretin-based therapy in MASH and obesity
2个月前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2个月前
已完结
Long QT syndrome
2个月前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk
4个月前
已完结
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
5个月前
已完结
Antimicrobial activity of zinc oxide (ZnO) nanoparticle againstKlebsiella pneumoniae
马来酸曲美布汀联合匹维溴铵治疗腹泻型肠易激综合征临床疗效评价
皖公网安备34019202002308
